Divison of Nuclear Medicines, Institute of Nuclear Medicine and Allied Sciences, DRDO, Delhi, 110054, India.
Center for Biomedical Engineering, Indian Institute of Technology, New Delhi, 110016, India.
AAPS PharmSciTech. 2021 Feb 16;22(3):76. doi: 10.1208/s12249-021-01944-9.
Collagen and chitosan have haemostatic, tissue fix and wound healing properties but the poor mechanical property limits their application. Therefore, various concentrations of collagen (1-6%) and chitosan (1-2%) were used to develop biopolymer-coated gauzes, with and without glycerol as plasticiser. Glycerol-treated gauzes showed desired mechanical and adhesive property in comparison to polymer-coated gauzes alone. Developed gauzes were characterized using differential scanning calorimetry, thermal gravimetric analysis and Fourier transform infrared spectrophotometry to confirm the biopolymer coating and stability. Scanning electron microscopy showed multilayer coating of the biopolymer and faster clotting in chitosan gauzes in comparison to collagen. Surface plasmon resonance assay confirmed that chitosan exhibited more binding affinity of 65 RU in comparison to collagen, which showed 55 RU with erythrocytes. Decrease in the value of plateletcrit and mean platelet volume confirmed platelet adhesion and aggregation over the surface of polymer-coated dressings. Gamma scintigraphy studies showed 85 ± 2% formulation retention up to 12 h at the wound site in comparison to 40 ± 3% retention of the radiopharmaceutical alone. Collagen and chitosan-coated gauze showed 226 ± 15 s and 179 ± 12 s haemostasis time, respectively, which was significantly less from 506 ± 15 s in standard gauze. Chitosan gauze showed faster wound healing in comparison to the collagen-coated gauze. Chitosan and collagen-coated gauzes showed 55 ± 4% wound contraction on day seven in comparison to 25 ± 2% in the control group, while chitosan gauzes showed complete wound contraction on day fourteenth, while the collagen-coated gauze showed 90 ± 3% on the same day.
胶原和壳聚糖具有止血、组织固定和伤口愈合的特性,但机械性能差限制了它们的应用。因此,使用不同浓度的胶原(1-6%)和壳聚糖(1-2%)开发了生物聚合物涂层纱布,有和没有甘油作为增塑剂。与单独的聚合物涂层纱布相比,甘油处理的纱布显示出所需的机械和粘附性能。通过差示扫描量热法、热重分析和傅里叶变换红外光谱法对开发的纱布进行了表征,以确认生物聚合物的涂层和稳定性。扫描电子显微镜显示,与胶原相比,生物聚合物的多层涂层和壳聚糖纱布的更快凝结。表面等离子体共振分析证实壳聚糖表现出 65 RU 的更高结合亲和力,而胶原蛋白显示出与红细胞的 55 RU。血小板比容和平均血小板体积值的降低证实了聚合物涂层敷料表面的血小板粘附和聚集。伽马闪烁成像研究表明,与单独的放射性药物相比,在伤口部位 12 小时内保留了 85±2%的配方,而保留了 40±3%。胶原蛋白和壳聚糖涂层纱布的止血时间分别为 226±15 s 和 179±12 s,明显短于标准纱布的 506±15 s。壳聚糖纱布的止血时间比胶原蛋白涂层纱布更快。壳聚糖和胶原蛋白涂层纱布在第 7 天的伤口收缩率分别为 55±4%和 25±2%,而对照组为 25±2%,而壳聚糖纱布在第 14 天完全收缩,而胶原蛋白涂层纱布在同一天显示 90±3%。